Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Vygon Acquires Macatt Medica, Peruvian Distributor of Single-use Medical Devices
Vygon, a specialist single-use medical devices group, today announces the acquisition of Macatt Medica, a […]
NEC OncoImmunity Acquires VAXIMM's Neoantigen Vaccine Development Assets
NEC OncoImmunity (NOI), a subsidiary of NEC Corporation (NEC), and VAXIMM AG, a Swiss/German biotech […]
Flow Eighteen38 Receives €5 Million EUR (c.$5.58 Million USD) to Expand Production and Biophysical Capabilities
Flow Eighteen38, a protein sciences division created to facilitate and accelerate antibody characterization and protein […]
Solvias Appoints Archie Cullen Chief Executive Officer
Solvias, one of the largest independent analytical testing, contract research, development and manufacturing companies, today […]
Targovax ASA and Agenus Announce Collaboration on Mutant KRAS Cancer Vaccine Adjuvanted with QS-21 STIMULON™
Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, […]
Orbit Discovery and WuXi AppTec Sign Agreement to Access Peptide Discovery and Optimisation Technologies
Orbit Discovery (Orbit), a ground-breaking peptide discovery company is pleased to announce the commencement of a […]
Maverick Medical AI Closes a $5M Seed Investment Round for Accelerating Development of its mCoder™ Artificial Intelligence Platform for Additional Clinical Domains
Maverick Medical AI (“Maverick”, the “Company”) has announced that it has closed a $5 million seed investment from […]
European Investment Bank to Provide a €7.5 Million Loan to Support Further Research and Development of Diadem's AlzoSure® Predict Blood Test for Alzheimer's Disease
The European Investment Bank (EIB) has awarded a €7.5 million loan to Diadem Srl, a […]
AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer
AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announce that Dr. […]
Tollys and Gustave Roussy Enter into New Research Agreement
Tollys, a biopharmaceutical company developing TL-532, the first anti-cancer immunotherapy based on a synthetic toll-like […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more